Serum PSA testing, multiparametric magnetic resonance imaging (mpMRI) and prostatic biopsy constitutes the standard diagnostic pathway for men with suspected prostate cancer in the National Health Service (NHS) in the UK [9]. This evidence concerns the gene KLK3 and Familial prostate cancer.